More positive news from Pfizer
CNN is reporting a final analysis of the Phase 3 trial for the company's coronavirus vaccine shows it was 95 percent effective in preventing infections, even in older adults and caused no serious safetyconcerns.
This supports Pfizer's claim last week that the two shot vaccine has an efficacy rate over 90 percent.
That means the vaccine has reached a key safety milestone that will allow the company to apply for Food and Drug Administration authorization within days.
If it gets the green light, Pfizer plans to start distributing the vaccine by the end of the year.
Family Christmas exemptions. Will we have covid vaccines in Canada by January? Emergency Medical Specialist Dr. Mitch Shulman joins Tim to discuss the latest Medical and Covid-19 stories of the week.
Western University graduate astronomy student Cole Gregg spotted a previously undiscovered asteroid flashing through the night sky on November 18 using a remote access telescope. Tim talks to Cole about the experience.
View from the drive thru for thursday Nov 26 "national interest exemption and loopholes"